Inventor · disambiguated record
Phani Ghanakota
Also filed as: GHANAKOTA PHANI
5 granted patents·6 pending applications·6 citations·filing 2020–2024
67Inventor score
Top patents by PatentIndex Score
11 records- 0192US11691963B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2021·Granted Jul 4, 2023·5 cites·30 claims
- 0284US12043632B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2021·Granted Jul 23, 2024·1 cites·35 claims
- 0373US2024254125A16-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitorsAJAX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0471US11970494B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2022·Granted Apr 30, 2024·0 cites·30 claims
- 0570US12275717B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2023·Granted Apr 15, 2025·0 cites·29 claims
- 0668US12162881B2Forms and compositions of inhibitors of JAK2AJAX THERAPEUTICS INC·Filed 2022·Granted Dec 10, 2024·0 cites·20 claims
- 0765US2024368157A1Forms and compositions of a jak2 inhibitorAJAX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0859US2024116892A1Heterocyclic amide and urea compounds as jak2 inhibitorsAJAX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0951US2024199634A1Cyclic compounds and methods of using sameSCHROEDINGER INC·Filed 2022·Application pending·0 cites
- 1050US2023365584A1Heterocyclic pericondensed cdc7 kinase inhibitors for the treatment of cancerSCHROEDINGER INC·Filed 2021·Application pending·0 cites
- 1148US2023101747A1Cyclic compounds and methods of using sameSCHROEDINGER INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Phani Ghanakota files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →